Teladoc Health, Inc. (TDOC) Financial Statements
Industry: Offices & Clinics of Doctors of Medicine (Services)
In fiscal 2025, Teladoc Health reported revenue of $2.53B, down 1.5% from $2.57B the year before. Net income was -$200.3M (a -7.9% net margin), or -$1.14 per diluted share. Gross margin was -10.4% and operating margin was -10.4%. Operating activities generated $294.4M of cash, leaving $285.5M of free cash flow. At fiscal year end, Teladoc Health held $2.86B in total assets against $1.47B in total liabilities, including $781.1M of cash and equivalents.
Open the full interactive Teladoc Health financials → Quarterly statements, key ratios, valuation history and price charts.
Teladoc Health Key Stats
| Share Price | $6.00 |
|---|---|
| Market Cap | $1.09B |
| Revenue YoY Growth | -1.5% |
| 52-Week Range | $4.47 – $9.72 |
| Shares Outstanding | 181.0 million (basic, 2026 Q2) |
Teladoc Health Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $1.09B | $2.03B | $2.41B | $2.60B | $2.57B | $2.53B |
| Cost of Goods Sold | $390.8M | $650.3M | $744.0M | $2.85B | $3.59B | $2.79B |
| Gross Profit | $703.1M | $1.38B | $1.66B | -$248.6M | -$1.02B | -$263.0M |
| Operating Income | -$506.4M | -$265.6M | -$13.65B | -$248.6M | -$1.02B | -$263.0M |
| Pre-Tax Income | -$576.0M | -$384.7M | -$13.66B | -$219.6M | -$993.7M | -$235.5M |
| Income Tax | -$90.9M | $44.1M | -$3.8M | $760,000 | $7.6M | -$35.2M |
| Net Income | -$485.1M | -$428.8M | -$13.66B | -$220.4M | -$1.00B | -$200.3M |
| Diluted EPS | -$5.36 | -$2.73 | -$84.60 | -$1.34 | -$5.87 | -$1.14 |
Teladoc Health Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $626.4M | $642.3M | $613.8M | $606.9M |
| Net Income | -$49.5M | -$25.1M | -$63.8M | -$38.9M |
| Diluted EPS | -$0.28 | -$0.14 | -$0.36 | -$0.21 |
Teladoc Health Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $733.3M | $893.5M | $918.2M | $1.12B | $1.30B | $781.1M |
| Current Assets | $1.06B | $1.23B | $1.32B | $1.49B | $1.66B | $1.12B |
| Total Assets | $17.76B | $17.73B | $4.35B | $4.39B | $3.52B | $2.86B |
| Current Liabilities | $332.6M | $331.0M | $399.8M | $420.6M | $941.5M | $404.7M |
| Total Long-Term Debt | $1.42B | $1.23B | $1.54B | $1.54B | $1.54B | $994.9M |
| Total Liabilities | $1.87B | $1.69B | $2.04B | $2.07B | $2.03B | $1.47B |
| Shareholders' Equity | $15.88B | $16.05B | $2.31B | $2.33B | $1.49B | $1.39B |
Teladoc Health Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$53.5M | $194.0M | $189.3M | $350.0M | $293.7M | $294.4M |
| Cash From Investing | -$591.0M | -$73.0M | -$167.7M | -$156.3M | -$124.1M | -$266.0M |
| Cash From Financing | $859.1M | $40.9M | $6.5M | $10.9M | $8.3M | -$551.7M |
| Free Cash Flow | -$57.5M | $185.5M | $172.8M | $338.6M | $282.9M | $285.5M |
Figures from Teladoc Health's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Teladoc Health financials page for every line item.
Teladoc Health Company Profile
| Ticker | TDOC |
|---|---|
| Exchange | NYSE |
| Industry | Offices & Clinics of Doctors of Medicine (Services) |
| Headquarters | New York, New York |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001477449 |
Frequently Asked Questions
What was Teladoc Health's revenue in fiscal 2025?
Teladoc Health (TDOC) reported revenue of $2.53B for fiscal 2025.
What is Teladoc Health's annual revenue history?
Teladoc Health's annual revenue by fiscal year: 2020: $1.09B; 2021: $2.03B; 2022: $2.41B; 2023: $2.60B; 2024: $2.57B; 2025: $2.53B.
What was Teladoc Health's net income in fiscal 2025?
Teladoc Health reported net income of -$200.3M for fiscal 2025.
What was Teladoc Health's earnings per share (EPS) in fiscal 2025?
Teladoc Health's diluted EPS was -$1.14 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Teladoc Health generate in fiscal 2025?
Teladoc Health generated $285.5M of free cash flow in fiscal 2025.
What was Teladoc Health's revenue last quarter?
In its most recent reported quarter (2026 Q2), Teladoc Health reported revenue of $606.9M.
How much debt does Teladoc Health have?
Teladoc Health reported $994.9M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Teladoc Health are outstanding?
Teladoc Health reported a weighted average of 181.0 million basic shares outstanding in 2026 Q2.
What is Teladoc Health's market cap?
Based on its latest closing price, Teladoc Health (TDOC) has a market capitalization of about $1.09B.
When does Teladoc Health's fiscal year end?
Teladoc Health's fiscal year end, as registered with the SEC, is December 31.
Where is Teladoc Health headquartered?
Teladoc Health lists its business address in New York, New York in its SEC filings.